Riskpilot← Back to searchSign inGet full accessMEDTEKPARTNER RESEARCH AS
ASActiveOrg 932172720Askekroken 11, 0277 OsloResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20230 employees
Revenue 2025
NOK 0
EBITDA margin
—
Equity ratio
100.0%
Financial strength
Net profit 2025
NOK -2K
0 employees
| Revenue | NOK 0 | — |
| EBITDA | NOK -2K | — |
| Net profit | NOK -2K | — |
| Total assets | NOK 28K | -6% |
| Equity | NOK 28K | -6% |
| Employees | 0 | — |
Legal name
MEDTEKPARTNER RESEARCH AS
Org number
932172720
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
3. oktober 2023
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Styrets leder og ett styremedlem i fellesskap. Daglig leder alene.
Company purpose
Å tilby forsknings og kliniske tjenester til medisinsk-tekniske, farmasøytiske, medisinske, bioteknologiske og helserelaterte selskaper. Dette inkluderer planlegging, gjennomføring og styring av kliniske studier, biostatistiske analyser, datamanagement, regulatorisk rådgivning og alle relaterte tjenester. Selskapet kan også engasjere seg i utvikling og kommersialisering av egne medisinske produkter og teknologier.
Address
Askekroken 11, 0277 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2024 | 2025 |
|---|---|---|
| Revenue | 0 | 0 |
| Staff expenses | −0 | −0 |
| EBITDA | 0 | −2 |
| Depreciation & amort. | −0 | −0 |
| EBIT | 0 | −2 |
| Net financials | 0 | 0 |
| Profit before tax | 0 | −2 |
| Tax | −0 | −0 |
| Net profit | 0 | −2 |
| Item | 2024 | 2025 |
|---|---|---|
| Total assets | 30 | 28 |
| Equity | 30 | 28 |
| Long-term debt | 0 | 0 |
| Short-term debt | 0 | 0 |
| Total debt | 0 | 0 |
EBITDA margin
-175500.0%
This company
15.8%
Market median
-1110859% vs market
20242025
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20242025
Return on equity
-6.2%
This company
18.4%
Market median
-134% vs market
20242025
Net profit margin
-175500.0%
This company
8.1%
Market median
-2166767% vs market
20242025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20242025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20242025
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2023 | |
| Board of Directors | 2023 | |
| Chairman | 2023 | |
| Board of Directors | 2023 | |
| Board of Directors | 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MEDTEKPARTNER RESEARCH AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Frode Kristiansen | Board of Directors | 0 companies |
| Alexander Stene Moen | Board of Directors | 0 companies |
| Magnus Reinsfelt Krogh | Chairman | 0 companies |
| Paul Bennett Gordon | Board of Directors | 0 companies |
| Erik Torgeir Fosse | Board of Directors | 0 companies |